Fitel Nom Ltd / Pfizer / MedImmune / Australian Stock Exchange / ABN Amro / Janssen 2 3 Top / Phylogica Limited / Roche/Genentech / Oxford BioMedica plc / /
Country
United Kingdom / /
Currency
USD / /
Event
Second Stock Issuance / /
Facility
University of Oxford / Telethon Institute / Murdoch University / University of Oxford Dr Richard Hopkins / /
Holiday
Commonwealth Day / /
IndustryTerm
pharmaceutical class / peptide drug discovery services / investment banking / /
Organization
Murdoch University / Harvard / Telethon Institute / University of Oxford / Discovery Alliance / /
Person
Achim Schenk / Paul Watt / Nick Woolf / Paul Fielding / Richard Hopkins / Douglas Wilson / Peter Hui / /
Position
CFO & VP Corporate Development 19 June / Prime Minister / CEO / Qualified accountant / Chairman / Chief Business Officer / COO & VP Research & Development / Senior Vice-President / CFO &biotech VP / Head / Vice-President / Medicine / VP Corporate / CFO & VP Corporate Development / /
BREAKTHROUGH PEPTIDE THERAPEUTICS Harnessing Biodiversity for Peptide Therapeutics Dr Paul Watt, CEO Mr Nick Woolf, CFO & VP Corporate Development 19 June 2013